Literature DB >> 22706020

Enhanced steroid response of a human glucocorticoid receptor splice variant.

Aaron C Baker1, Tajia L Green, Victoria W Chew, Kelly Tung, Amir Amini, Debora Lim, Kiho Cho, David G Greenhalgh.   

Abstract

Glucocorticoids remain a recommended therapy in advanced septic shock despite the often unpredictable response, and our understanding of the mechanisms regulating the steroid and stress response remains limited. Since the initial sequencing of the human glucocorticoid receptor α and β gene (hGRα and hGRβ), only three additional splice variants have been identified--all of which have been postulated to contribute to steroid resistance. During a survey of 97 healthy humans' blood, we identified two novel hGR splice isoforms (hGR-S1 and hGR-S1(-349A) retaining intron H between exons 8 and 9. Human GR-S1(-349A) contained a base deletion causing an early termination and a truncated protein of 118 amino acids, whereas hGR-S1 had an early termination occurring within intron H and resulted in a 745-amino acid protein. Both isoforms had decreased transactivation potentials compared with hGRα when tested in the absence of exogenous steroids. However, after treating with exogenous steroids, dose-response studies showed hGR-S1(-349A) had a substantial augmentation in activity at higher concentrations of hydrocortisone and methylprednisolone when compared with hGRα, whereas hGR-S1 did not. Removal of the 3' untranslated region (3'UTR) of the hGR-S1(-349A) mRNA sequence resulted in a loss of the augmented response. The isoform hGR-S1(-349A) augments the response to steroids, and this significant response appears to be critically regulated by the 3'UTR. The identification and evaluation of these unique hGR isoforms helps further the understanding of the complex genetic regulation of the stress and steroid response.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22706020     DOI: 10.1097/SHK.0b013e318257c0c0

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  7 in total

Review 1.  MicroRNAs as tools to predict glucocorticoid response in inflammatory bowel diseases.

Authors:  Sara De Iudicibus; Marianna Lucafò; Stefano Martelossi; Chiara Pierobon; Alessandro Ventura; Giuliana Decorti
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

Review 2.  The Interactome of the Glucocorticoid Receptor and Its Influence on the Actions of Glucocorticoids in Combatting Inflammatory and Infectious Diseases.

Authors:  Ioanna Petta; Lien Dejager; Marlies Ballegeer; Sam Lievens; Jan Tavernier; Karolien De Bosscher; Claude Libert
Journal:  Microbiol Mol Biol Rev       Date:  2016-05-11       Impact factor: 11.056

Review 3.  Pharmacogenetics and interstitial lung disease.

Authors:  Justin M Oldham; Imre Noth; Fernando J Martinez
Journal:  Curr Opin Pulm Med       Date:  2016-09       Impact factor: 3.155

Review 4.  Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor.

Authors:  Nicolas C Nicolaides; Evangelia Charmandari; George P Chrousos; Tomoshige Kino
Journal:  BMC Endocr Disord       Date:  2014-08-25       Impact factor: 2.763

5.  A novel human glucocorticoid receptor SNP results in increased transactivation potential.

Authors:  Tajia L Green; Kelly Tung; Debora Lim; Stacey M Leventhal; Kiho Cho; David G Greenhalgh
Journal:  Biochem Biophys Rep       Date:  2016-12-18

6.  Uncovering a multitude of human glucocorticoid receptor variants: an expansive survey of a single gene.

Authors:  Stacey M Leventhal; Debora Lim; Tajia L Green; Anna E Cantrell; Kiho Cho; David G Greenhalgh
Journal:  BMC Genet       Date:  2019-02-08       Impact factor: 2.797

7.  Restrained expression of canine glucocorticoid receptor splice variants α and P prognosticates fatal disease outcome in SIRS.

Authors:  Brigitta Margit Kállai; Judit Csöndes; Gergely Kiss; Lilla Bodrogi; Zsolt Rónai; Tamás Mészáros
Journal:  Sci Rep       Date:  2021-12-30       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.